Downregulation of Duffy antigen receptor for chemokine (DARC) is associated with lymph node metastasis in human breast cancer.
- Author:
Zhou-luo OU
1
;
Jie WANG
;
Yi-feng HOU
;
Jian-min LUO
;
Zhen-zhou SHEN
;
Zhi-min SHAO
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Aged; Aged, 80 and over; Antigens, CD34; analysis; Bone Neoplasms; metabolism; secondary; Breast Neoplasms; blood supply; metabolism; pathology; Down-Regulation; Duffy Blood-Group System; metabolism; Female; Humans; Immunohistochemistry; Liver Neoplasms; metabolism; secondary; Lung Neoplasms; metabolism; secondary; Lymphatic Metastasis; Middle Aged; Neovascularization, Pathologic; metabolism; pathology; Receptors, Cell Surface; metabolism; Survival Analysis
- From: Chinese Journal of Oncology 2006;28(8):586-589
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo analyze the relationship between Duffy antigen receptor for chemokines (DARC) and the metastasis potential in human breast cancer. METHODS Breast cancer tissue sections from 75 patients, grouped according to the local lymph node status were examined immunohistochemically for protein level of DARC. Microvessel density (MVD) was counted by endothelial cells immunostained using anti-CD34 antibody.
RESULTSStrong positive DARC immunostaining in lymph node negative and positive groups was detected in 31 cases (81.6%) and 18 cases (48.6%), respectively (P < 0.01). MVD was (35.67 +/- 17.96)/HP and (53.38 +/- 20.29)/HP in DARC strong positive and less positive cases (P < 0.01). In those patients with lung, bone, hepatic distant metastasis (13 cases), 9 cases (69.2%) were DARC less positive, 4 cases (30.8%) were DARC strong positive. The correlation coefficient was -0.412 between DARC expression and MVD and the corresponding value was -0.346 between DARC expression and lymph node status and -0.333 between DARC expression and distant metastasis in breast cancer.
CONCLUSIONDARC may play a negative role in the process of neoangiogenesis, and probably has an association with the lymph node status.
